Poly Medicure Limited (NSE:POLYMED)
India · Delayed Price · Currency is INR 1,654.00
+39.70 (2.46%)
Nov 11, 2026, 1:15 PM IST
Poly Medicure Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 167,742 | 120,699 | 227,182 | 152,478 | 91,445 | 90,990 | |
Market Cap Growth | -12.59% | -46.87% | 48.99% | 66.74% | 0.50% | 16.07% |
Enterprise Value | 164,107 | 112,271 | 216,276 | 151,031 | 89,453 | 88,313 |
Last Close Price | 1614.30 | 1188.67 | 2236.73 | 1581.27 | 945.91 | 940.19 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 52.72 | 37.47 | 67.10 | 59.04 | 51.01 | 62.11 |
PS Ratio | 7.68 | 6.44 | 13.61 | 11.08 | 8.20 | 9.86 |
PB Ratio | 4.96 | 3.83 | 8.21 | 10.37 | 7.37 | 8.37 |
P/TBV Ratio | 5.88 | 4.53 | 8.38 | 10.77 | 7.68 | 8.78 |
P/OCF Ratio | 62.10 | 48.99 | 97.48 | 57.31 | 47.86 | 73.69 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 7.51 | 5.99 | 12.95 | 10.98 | 8.02 | 9.57 |
EV/EBITDA Ratio | 32.56 | 25.51 | 47.83 | 42.22 | 33.41 | 41.70 |
EV/EBIT Ratio | 45.19 | 34.12 | 58.20 | 50.97 | 42.04 | 55.33 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.13 | 0.11 | 0.07 | 0.12 | 0.12 | 0.12 |
Debt / EBITDA Ratio | 0.85 | 0.80 | 0.40 | 0.48 | 0.55 | 0.60 |
Net Debt / Equity Ratio | -0.12 | -0.15 | -0.37 | -0.08 | -0.12 | -0.21 |
Net Debt / EBITDA Ratio | -0.84 | -1.07 | -2.27 | -0.31 | -0.57 | -1.06 |
Net Debt / FCF Ratio | 35.58 | 7.63 | 10.48 | 10.25 | 3.16 | 7.01 |
Asset Turnover | 0.55 | 0.53 | 0.66 | 0.80 | 0.76 | 0.71 |
Inventory Turnover | 1.52 | 1.60 | 2.14 | 2.27 | 2.17 | 2.38 |
Quick Ratio | 2.12 | 2.40 | 4.28 | 1.65 | 1.88 | 2.54 |
Current Ratio | 3.13 | 3.37 | 5.19 | 2.40 | 2.75 | 3.46 |
Return on Equity (ROE) | 10.14% | 10.85% | 15.99% | 19.05% | 15.39% | 14.27% |
Return on Assets (ROA) | 5.62% | 5.78% | 9.20% | 10.78% | 9.00% | 7.67% |
Return on Invested Capital (ROIC) | 9.28% | 11.18% | 17.95% | 18.16% | 16.46% | 15.05% |
Return on Capital Employed (ROCE) | 9.90% | 9.80% | 13.20% | 19.70% | 16.60% | 13.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.90% | 2.67% | 1.49% | 1.69% | 1.96% | 1.61% |
FCF Yield | -0.07% | -0.51% | -0.43% | -0.07% | -0.53% | -0.35% |
Dividend Yield | 0.21% | 0.29% | 0.16% | 0.19% | 0.32% | 0.26% |
Payout Ratio | 21.27% | 11.00% | 8.96% | 11.13% | 13.37% | 16.32% |
Buyback Yield / Dilution | 0.19% | -2.22% | -3.36% | 0.00% | -0.06% | -7.64% |
Total Shareholder Return | 0.41% | -1.93% | -3.20% | 0.19% | 0.26% | -7.37% |